About UCSF Search UCSF UCSF Medical Center

Catherine Smith, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
smith_catherine

Assistant Professor, Division of Hematology/Oncology, Department of Medicine, UCSF

csmith@medicine.ucsf.edu

Phone: 476-9553 (voice)
Box 1270, UCSF
San Francisco, CA 94143-1270

View on UCSF Profiles


Additional Websites


Education

Yale University, CT, BS, 1998, Chemistry
Duke University, MD, 2002, Medicine


Professional Experience

  • 7/2002-6/2005
    Residency, Internal Medicine, Brigham and Women's Hospital, Harvard Medical School
  • 7/2005-6/2006
    Clinical Instructor, Department of Medicine, University of California at San Francisco
  • 7/2006-7/2009
    Fellow, Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco
  • 8/2009-6/2011
    Adjunct Instructor, Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco
  • 7/2011-present
    Assistant Professor, Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco

Honors & Awards

  • 2010
    Leukemia and Lymphoma Society Special Fellow in Clinical Research Career Development Award
  • 2010
    European Hematology Association/American Society of Hematology Translational Research Training Program Award
  • 2009
    American Society of Hematology Research Training Award for Fellows, Finalist
  • 2002
    American Medical Women's Association, Inc. Janet M. Glasgow Memorial Achievement Citation Awarded to graduating women medical students who graduate in the top 10% of their class.
  • 2002
    E. E. Owen, M.D. Clinical Scholar Award Awarded to 2 graduating medical students for clinical excellence.
  • 2001
    William G. Anylan Scholarship Awarded to 4th year medical students deserving recognition based on academics, service to the medical school and commitment to the profession.
  • 2000
    Alpha Omega Alpha
  • 2000-2001
    Howard Hughes Medical Institute Research (HHMI) Medical Student Training Fellowship
  • 1998
    Cum Laude, Yale University
  • 1998
    Howard Douglass Moore Prize Awarded for excellence in the field of chemistry at Yale University.
  • 1998
    Michael T. Manzella Award Presented to the senior who through the qualities of kindness, dedication and courage most inspired classmates in Timothy Dwight College at Yale.
  • 1997
    National Institutes of Health (NIH) Summer Research Internship
  • 1996
    Howard Hughes Medical Institute (HHMI) Summer Research Fellowship

Selected Publications

  1. Sudhindra A, Smith CC. FLT3 Inhibitors in AML: Are We There Yet? Curr Hematol Malig Rep. 2014 Mar 30.
    View on PubMed
  2. Smith CC, Lasater EA, Lin KC, Wang Q, McCreery MQ, Stewart WK, Damon LE, Perl AE, Jeschke GR, Sugita M, Carroll M, Kogan SC, Kuriyan J, Shah NP. Crenolanib is a selective type I pan-FLT3 inhibitor. Proc Natl Acad Sci U S A. 2014 Apr 8; 111(14):5319-24.
    View on PubMed
  3. Smith CC. Disease diversity and FLT3 mutations. Proc Natl Acad Sci U S A. 2013 Dec 24; 110(52):20860-1.
    View on PubMed
  4. Smith CC, Lasater EA, Zhu X, Lin KC, Stewart WK, Damon LE, Salerno S, Shah NP. Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD. Blood. 2013 Apr 18; 121(16):3165-71.
    View on PubMed
  5. Smith CC, Shah NP. The role of kinase inhibitors in the treatment of patients with acute myeloid leukemia. Am Soc Clin Oncol Educ Book. 2013; 33:313-8.
    View on PubMed
  6. Smith CC, Wang Q, Chin CS, Salerno S, Damon LE, Levis MJ, Perl AE, Travers KJ, Wang S, Hunt JP, Zarrinkar PP, Schadt EE, Kasarskis A, Kuriyan J, Shah NP. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature. 2012 May 10; 485(7397):260-3.
    View on PubMed
  7. Smith CC, Shah NP. Mechanisms of resistance to targeted therapies in acute myeloid leukemia and chronic myeloid leukemia. Am Soc Clin Oncol Educ Book. 2012; 685-9.
    View on PubMed
  8. Smith CC, Shah NP. Is it downhill from here? Eliminating leukemic stem cells and curing chronic myeloid leukemia. Clin Cancer Res. 2011 Nov 1; 17(21):6605-7.
    View on PubMed
  9. Smith CC, Shah NP. Tyrosine kinase inhibitor therapy for chronic myeloid leukemia: approach to patients with treatment-naive or refractory chronic-phase disease. Hematology Am Soc Hematol Educ Program. 2011; 2011:121-7.
    View on PubMed
  10. Kaimal AJ, Smith CC, Laros RK, Caughey AB, Cheng YW. Cost-effectiveness of private umbilical cord blood banking. Obstet Gynecol. 2009 Oct; 114(4):848-55.
    View on PubMed

Go to UCSF Profiles, powered by CTSI